Panel Will Discuss Quality by Design at INTERPHEX
Pharmaceutical Technology will be moderating a panel discussion, “Lessons Learned: Successes and Challenges in Implementing Quality by Design,” on Wednesday Apr. 24 from 10:15 to 11:15 at INTERPHEX in New York City.

A World Without Polio by 2018
More than 400 eminent scientists and public health experts from around the world have come together to endorse a new initiative to eradicate polio by 2018. The Scientific Declaration on Polio Eradication, published on Apr. 11, 2013, stated that an end to polio is scientifically feasible and achievable.

FDA Will Not Approve Generics to Original OxyContin
The FDA approved updated labeling for Purdue Pharma L.P.’s reformulated OxyContin tablets, but also determined that it will not approve generic versions of the original OxyContin.

FDA Commissioner Claims Resistance to Compounding Pharmacy Inspections
FDA inspections of compounding pharmacies manufacturing sterile products reveal non-sterile conditions.

FDA Requests Almost $5 Billion for 2014 Budget
FDA’s Fiscal Year 2014 budget request includes more than $10 million above the 2012 budget for inspections of products manufactured in China.

Advertisement: Tablet manufacturing problems? By partnering with Long Island University, Natoli Engineering has developed the Natoli Engineering Institute for Industrial Pharmacy Development and Research. Our mission is to provide customers with unique product solutions to their specific issues based on a combination of science and experience. Learn More!

Pfizer Issued Warning Letter for Italian Manufacturing Plant
FDA has notified Pfizer of GMP violations at its facility in Catania, Italy.

Advertisement: WEBINAR ON ACCURATE QUOTING: HOW YOUR RFQ CAN LEAD THE WAY Ensure an accurate quote from your CDMO by providing the right information up front. In this quickinar (quick webinar) from Metrics, Inc., Ed Patel examines the six key sections of a comprehensive RFQ. You'll also receive access to an RFQ template that follows these best practices. The 15-minute pre-recorded session can be viewed at the following link. Read More

FDA Releases Guidance on Self-Selections Studies
FDA has released recommendations on the development and conduction of self-selection studies in support of applications for nonprescription drug products.

Advertisement: Connect with 16,500 biotech professionals from 65 countries at the 2013 BIO International Convention in Chicago, April 22 – 25, for unparalleled partnering opportunities, expert insights and the latest technology discoveries. Choose from 125 targeted and timely education sessions. See the latest technology trends from 2,000+ leading suppliers and get a snapshot of global industry progress in 60+ state and country pavilions. Register now.

Roche Will Use Technology From Isis to Develop Brain-disorder Drug
Roche and Isis Pharmaceuticals have formed an alliance to develop treatments for Huntington’s disease based on Isis’ antisense oligonucleotide technology.

Vetter’s New Commercial Line Validated for cGMP Filling
Vetter’s prefilled-syringe line features automation and novel disinfection techniques.

Thermo Fisher Scientific to Acquire Life Technologies
$13.6 billion deal strengthens Thermo’s leading role.

Amgen to Pay $24.9 Million for False Claims Act Violations
Amgen Inc. has agreed to pay the United States $24.9 million to settle allegations that it violated the False Claims Act.